Replies to post #491120 on Anavex Life Sciences Corp (AVXL)

[IhidfromtheX]

It's nice to speculate on the future, but this isn't helping us currently...We need current news!

[Bourbon_on_my_cornflakes]

If, a big if, AVXL were taking in $30 billion revenues, that would be at least $13 billion net income until patents expire in 2035.

I would want to see $12 billion of that dividended, as there is no way AVXL could reinvest that much $$$.

The numbers would be wild and crazy. $120 per share div.

5 multiple = $600 a share
10 multiple = $1200
20 multiple - $2400

crazy fever dream numbers, not reality

[LarryMexico28]

That's delusional

[subluxed]

Flaconer, while I love your numbers, I just do not think AVXL will exist as it does by the time the dividends will start.
Once the price is right, Missling will be selling the company. In order to get his desired price (triple digits) Blarcamesine will be approved by EMA, with FDA on deck.
3-71 for Schitzo will be in Phase 3 trials or up for approval as well.
The big question is what's it going to take for Missling to say YES!$

[tredenwater2]

“Whew!” is right. Chop it in half for a partnership and half it again for shits n grins. Chalk it up after all this shettin in the wind and shareholders will stand, wipe their foreheads and still let out a “WHEW!”

#Dr.MisslingsGettinerdun!

[sumbuysumsell]

You might want to check them numbers………..

Some eighth-grade arithmetic.

What might happen if Anavex is able to sell blarcamesine in the EU and would consequently take in $30 billion in annual revenues?

If there were an even 100 million outstanding AVXL shares, that would be a per-share annual revenue stream of $500. If, then, there were a 5% dividend dropdown (payout) that would be an annual dividend disbursement of $25 per share.